# Allergopharma GmbH & Co. KG clinical trials: 23 (2026)

ClinicalTrials.gov lists 23 trials with Allergopharma GmbH & Co. KG as lead sponsor, 1 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Allergopharma GmbH & Co. KG: 23 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/allergopharma-gmbh-and-co-kg

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 31, 2025 | NCT07096440 | Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust Mites | Allergopharma GmbH & Co. KG | Observational | Not yet recruiting | Allergic Rhinitis Due to House Dust Mite, Allergic Conjunctivitis Due to Dermatophagoides Farinae, Allergic... | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07096440) |
| November 21, 2014 | NCT02297490 | Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials | Allergopharma GmbH & Co. KG | Phase 2 | Terminated | Allergic Rhinoconjunctivitis, Healthy Volunteers | 158 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02297490) |
| December 13, 2011 | NCT01490411 | Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis | Allergopharma GmbH & Co. KG | Phase 2 | Completed | Allergic Rhinoconjunctivitis | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01490411) |
| May 16, 2011 | NCT01353755 | 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Rhinoconjunctivitis, Allergic Asthma | 195 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01353755) |
| February 11, 2009 | NCT00841516 | Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative | Allergopharma GmbH & Co. KG | Phase 2 | Completed | Allergic Rhinoconjunctivitis | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00841516) |
| February 11, 2009 | NCT00841256 | Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Allergic Rhinoconjunctivitis | 207 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00841256) |
| January 7, 2009 | NCT00818181 | Open Label Safety Study of a Birch Pollen Allergen Extract | Allergopharma GmbH & Co. KG | Phase 2 | Completed | Rhinoconjunctivitis | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00818181) |
| May 5, 2008 | NCT00671268 | Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto... | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Rhinoconjunctivitis | 256 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00671268) |
| April 24, 2008 | NCT00666341 | Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens | Allergopharma GmbH & Co. KG | Phase 2 | Completed | Type I-Allergy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00666341) |
| April 24, 2008 | NCT00665483 | Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture. | Allergopharma GmbH & Co. KG | Phase 4 | Completed | Type I Allergy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00665483) |
| February 26, 2008 | NCT00623701 | Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Allergy, Rhinitis, Conjunctivitis | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00623701) |
| November 7, 2007 | NCT00554983 | Efficacy and Safety From a Recombinant Folding Variant of Bet v 1 | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Allergy | 255 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00554983) |
| October 8, 2007 | NCT00540631 | Multicenter Trial of Immunotherapy With House Dust Mite Allergoid | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Rhinoconjunctivitis | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00540631) |
| March 31, 2006 | NCT00309062 | Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Birch Pollen Allergy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00309062) |
| March 31, 2006 | NCT00309036 | Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Allergy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00309036) |
| December 19, 2005 | NCT00266526 | Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV | Allergopharma GmbH & Co. KG | Phase 2 | Completed | Birch Pollen Allergy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00266526) |
| December 13, 2005 | NCT00264459 | Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Grass Pollen Allergy | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00264459) |
| December 12, 2005 | NCT00263952 | Efficacy and Safety of a Purified Standardised Bee Venom Preparation | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Bee Venom Allergy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00263952) |
| December 12, 2005 | NCT00263926 | Efficacy and Safety of a Purified Standardised Wasp Venom Preparation | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Allergy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00263926) |
| December 9, 2005 | NCT00263640 | Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Respiratory Hypersensitivity | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00263640) |
| December 9, 2005 | NCT00263627 | Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Pollen Allergy | 253 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00263627) |
| December 9, 2005 | NCT00263601 | Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis | Allergopharma GmbH & Co. KG | Phase 3 | Completed | Grass Pollen Allergy | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00263601) |
| December 9, 2005 | NCT00263549 | Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis | Allergopharma GmbH & Co. KG | Phase 4 | Completed | House Dust Mite Allergy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00263549) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 6 |
| Phase 3 | 14 |
| Phase 4 | 2 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 21 |
| Terminated | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hypersensitivity | 9 |
| Venom Hypersensitivity | 2 |
| Dust Mite Allergy | 2 |
| Rhinitis | 2 |
| Asthma | 2 |
| Respiratory Hypersensitivity | 1 |
| Conjunctivitis | 1 |
| Rhinitis, Allergic, Seasonal | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Wallpaper installers in the United States](https://specstream.ai/data/businesses/wallpaper-installers/united-states)
- [Language schools in the United States](https://specstream.ai/data/businesses/language-schools/united-states)
- [Blueprint printers in the United States](https://specstream.ai/data/businesses/blueprint-printers/united-states)
- [Pool and hot tub services in the United States](https://specstream.ai/data/businesses/pool-and-hot-tub-services/united-states)
- [Electrical wholesalers in the United States](https://specstream.ai/data/businesses/electrical-wholesalers/united-states)
- [Tiling contractors in the United States](https://specstream.ai/data/businesses/tiling-contractors/united-states)
